Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 55 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

16%

9 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

16 recruiting

Enrollment Performance

Analytics

N/A
13(44.8%)
Phase 4
5(17.2%)
Phase 3
4(13.8%)
Phase 1
3(10.3%)
Phase 2
3(10.3%)
Early Phase 1
1(3.4%)
29Total
N/A(13)
Phase 4(5)
Phase 3(4)
Phase 1(3)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (55)

Showing 20 of 55 trials
NCT06696820Phase 2Completed

Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke

Role: collaborator

NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT07595068Not ApplicableNot Yet Recruiting

Low-Intensity Focused Ultrasound Targeting the Stellate Ganglion for Regulating Autonomic Nerve Function and Sleep Quality in Perioperative Patients With Cardiovascular Diseases

Role: collaborator

NCT07002346Phase 3Recruiting

INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma

Role: collaborator

NCT07593833Not Yet Recruiting

Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection

Role: collaborator

NCT07587294Not ApplicableNot Yet Recruiting

Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial Infarction

Role: collaborator

NCT07410403Enrolling By Invitation

AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities

Role: collaborator

NCT07077486Phase 4Recruiting

Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

Role: collaborator

NCT05303285Phase 4Recruiting

A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis

Role: collaborator

NCT07361783Not ApplicableRecruiting

Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI 2 Trial

Role: collaborator

NCT07240467Phase 2Not Yet Recruiting

Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness

Role: collaborator

NCT07288749Phase 3Not Yet Recruiting

Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

Role: collaborator

NCT04852562Not ApplicableCompleted

The Effect of Modified Radical Endoscopic Sinus Surgery on Eosinopilic Chronic Rhinosinusitus With Nasal Polyps

Role: collaborator

NCT07152639Phase 3Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above

Role: collaborator

NCT06280313Recruiting

Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension

Role: collaborator

NCT07106411Not Yet Recruiting

CEH-EUS for Differentiating GISTs and Leiomyomas: A Multicenter Prospective Self-Controlled Study

Role: collaborator

NCT05983003Completed

Research on Identifying and Treatment Prognosis of Chronic Rhinosinusitis Based on Image and Sequencing Data

Role: collaborator

NCT07048353Early Phase 1Not Yet Recruiting

CD30 CAR-T in the Treatment of CD30 Positive Lymphoma

Role: collaborator

NCT05614050Recruiting

The Prognosis of Patients After PCI:a Multi-center Study in China

Role: collaborator

NCT07019012Phase 4Recruiting

Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.

Role: collaborator